Figure 1.
Study design. Design of the phase 1/2 open-label, single ascending dose–finding 101HEMB01 study of DTX101, and the noninterventional follow-up 101HEMB02 study.

Study design. Design of the phase 1/2 open-label, single ascending dose–finding 101HEMB01 study of DTX101, and the noninterventional follow-up 101HEMB02 study.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal